With Dupixent's Patent Clock Ticking, Sanofi Circles Insmed
Source: Benzinga ·

Insmed Inc. (NASDAQ:INSM) stock surged Thursday following a report that French pharmaceutical giant Sanofi SA (NASDAQ:SNY) is exploring a potential acquisition of the respiratory disease specialist. The potential acquisition comes as Sanofi seeks new growth opportunities to reduc
Read the full story at Benzinga
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.